Newton, MA, United States of America

Jonathan Kay

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2006-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Kay. Retrieved from https://idiyas.com/inventor/jonathan-kay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Newton Centre, ME (US) (2006)
  • Newton Centre, MA (US) (2011)

Company Filing History:


Years Active: 2006-2011

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jonathan Kay in Anemia Treatment

Introduction

Jonathan Kay is an accomplished inventor based in Newton Centre, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of blood disorders. With a total of 2 patents, his work focuses on innovative methods to address anemia.

Latest Patents

One of Jonathan Kay's latest patents is a method of treating anemia by administering IL-1ra. This invention relates to methods of treating a blood disorder in a mammal using an interleukin-1 (IL-1) inhibitor. Additionally, it encompasses methods that combine an IL-1 inhibitor, a TNF inhibitor, and an erythropoietin (EPO) receptor agonist. The invention also includes compositions that utilize these inhibitors to enhance treatment efficacy.

Career Highlights

Jonathan Kay is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to further develop his innovative ideas and contribute to advancements in medical treatments.

Collaborations

Throughout his career, Jonathan has collaborated with notable colleagues, including Dorothy McCabe and Richard Newmark. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Jonathan Kay's contributions to the field of anemia treatment through his innovative patents highlight his dedication to improving healthcare. His work continues to pave the way for new therapeutic approaches in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…